A pan UAE Breast Cancer Initiative
About Pink Caravan
A pan UAE breast cancer initiative
Pink Caravan is a Pan UAE breast cancer initiative that falls under Friends of Cancer Patients’ umbrella “Kashf” for early detection of cancer.
Launched in 2011 under the patronage of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Member of the Supreme Council and Ruler of Sharjah and Her Highness Sheikha Jawaher Bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah, Founder and Royal Patron of the Friends of Cancer Patients Society (FoCP), International Ambassador of the World Cancer Declaration for Union for International Cancer Control (UICC) and International Ambassador for Childhood Cancer for UICC, Pink Caravan aims to raise awareness around breast cancer early detection and screening methods, lobby for the creation of the first UAE National Cancer Registry, and raise sufficient funds to purchase and operate a state of the art mobile mammography unit.
The initiative has garnered widespread recognition locally, regionally, and internationally, and therefore, has appointed ambassadors from different walks of life to promote and advocate its mission.
In a bid to extend the scope of awareness, Pink Caravan annually runs the Pink Caravan Ride, throughout the seven emirates reaching remote areas. Each year over 150 experienced equine riders join forces, garnering support across different sectors, bringing together schools, universities, corporations, Pink Caravan ambassadors and royalty. Pink Caravan Ride to date has travelled over 1,150 km across the seven emirates, with over 350 riders, 300 volunteers and 410 medical clinics offering early breast cancer detection examinations for 34,400 people, including 7,873 men. Pink Caravan Ride has also visited 84 schools delivering educational sessions and lectures about the importance of early detection of breast cancer.
In June 2012 Pink Caravan and University Hospital Sharjah signed a memorandum of understanding marking the beginning of the ‘Cancer Centre of Excellence’ operated in early 2013 in collaboration with The Institute Gustave-Roussy (IGR), the leading European oncology centre, to provide treatment to needy cancer patients free of cost.